ArticlePloS one2012

Serum YKL-40 independently predicts outcome after transcatheter arterial chemoembolization of hepatocellular carcinoma.

Cheng-Bao Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.